Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches

By Kerbel R.S.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 1-2, 2001-03 ,pp. : 81-88

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies

By          

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1742-1748

Spandidos Publications

Access to resources Recommend Favorite

Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer

By Kanai Masashi   Matsumoto Shigemi   Nishimura Takahumi   Shimada Yutaka   Watanabe Go   Kitano Toshiyuki   Misawa Akiko   Ishiguro Hiroshi   Yoshikawa Kiyotsugu   Yanagihara Kazuhiro   Teramukai Satoshi   Mitsumori Michihide   Chiba Tsutomu   Sakai Yoshiharu   Fukushima Masanori  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 224-227

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of Combination Therapy Versus Monotherapy

By Krainer Michael  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 11-15

Springer Publishing Company

Access to resources Recommend Favorite

Combination of Phytochemicals as Adjuvants for Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 3, 2014-09 ,pp. : 297-302

Bentham Science Publishers

Access to resources Recommend Favorite